Expanding Use of Trikafta for Cystic Fibrosis to Patients as Young as 2 Years Old
Expanding Use of Trikafta for Cystic Fibrosis to Patients as Young as 2 Years Old https://pediatricsnationwide.org/wp-content/uploads/2021/08/MicrosoftTeams-image-1-1024x683.jpg 1024 683 Karen McCoy, MD https://secure.gravatar.com/avatar/?s=96&d=mm&r=gWhen I first started my pulmonary training, the average life expectancy in the United States was about 70 years, and the average life expectancy for someone with cystic fibrosis (CF) was 14 years! Intense study and pursuit of consistent care across the country yielded improvements. By 2010, with standards of treatment very consistent and implementation…